Encompass Health (AMEX:EHC) issued an update on its FY 2019 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $3.71-3.85 for the period, compared to the Thomson Reuters consensus estimate of $3.79. The company issued revenue guidance of $4.5-4.6 billion, compared to the consensus revenue estimate of $4.57 billion.Encompass Health also updated its FY19 guidance to $3.71-3.85 EPS.

Several equities analysts have commented on the stock. Zacks Investment Research downgraded shares of Hancock Jaffe Laboratories from a buy rating to a hold rating in a report on Wednesday, June 26th. BMO Capital Markets assumed coverage on shares of Encompass Health in a report on Thursday, June 27th. They issued an outperform rating and a $72.00 price objective on the stock. Finally, Barclays upgraded shares of Encompass Health from an equal weight rating to an overweight rating and upped their price objective for the company from $68.00 to $70.00 in a report on Thursday, May 30th. Five research analysts have rated the stock with a buy rating, The stock currently has an average rating of Buy and a consensus price target of $74.50.

Encompass Health has a fifty-two week low of $40.86 and a fifty-two week high of $59.29.

Encompass Health (AMEX:EHC) last released its quarterly earnings results on Thursday, April 25th. The company reported $1.04 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.89 by $0.15. The business had revenue of $1.12 billion during the quarter, compared to analyst estimates of $1.12 billion. During the same quarter last year, the company posted $0.93 earnings per share. The company’s revenue was up 7.5% on a year-over-year basis.

The firm also recently declared a quarterly dividend, which was paid on Monday, July 15th. Investors of record on Monday, July 1st were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, June 28th. This represents a $1.08 annualized dividend and a dividend yield of ∞.

In related news, CEO Mark J. Tarr sold 67,382 shares of the company’s stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $63.56, for a total value of $4,282,799.92. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 1.60% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Featured Article: What is an SEC Filing?

Earnings History and Estimates for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.